Cargando…
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study
BACKGROUND: The prognosis of patients with hepatocellular carcinoma (HCC) undergoing transarterial chemoembolization (TACE) is variable, despite a myriad of prognostic markers. We compared and integrated the established prognostic models, HAP and ART scores, for their accuracy of overall survival (O...
Autores principales: | Pinato, David J., Arizumi, Tadaaki, Jang, Jeong Won, Allara, Elias, Suppiah, Puvan I., Smirne, Carlo, Tait, Paul, Pai, Madhava, Grossi, Glenda, Kim, Young Woon, Pirisi, Mario, Kudo, Masatoshi, Sharma, Rohini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190130/ https://www.ncbi.nlm.nih.gov/pubmed/27244889 http://dx.doi.org/10.18632/oncotarget.9604 |
Ejemplares similares
-
Prognostic sub-classification of intermediate-stage hepatocellular carcinoma: a multicenter cohort study with propensity score analysis
por: Ramaswami, Ramya, et al.
Publicado: (2016) -
Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma
por: Pinato, David J., et al.
Publicado: (2018) -
Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
por: Hajiev, Saur, et al.
Publicado: (2021) -
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study
por: Hajiev, Saur, et al.
Publicado: (2020) -
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib
por: Howell, Jessica A., et al.
Publicado: (2017)